Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With StatinsS. Matthijs Boekholdt, John J.P. Kastelein, Benoît J. Arsenault et al.|JAMA|2012Cited by 800
“Stress” and coronary heart disease: psychosocial risk factorsStephen Bunker, Andrew Tonkin, Denise Ruth et al.|The Medical Journal of Australia|2003Cited by 561
Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular DiseaseCharles H. Hennekens, René Belder, Frank M. Sacks et al.|Archives of Internal Medicine|2004Cited by 111
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: Randomized and observational comparisons of secondary prevention trials and their meta-analysisCharles H. Hennekens, René Belder, Frank M. Sacks et al.|Journal of the American College of Cardiology|2003Cited by 6